Article
TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma.
The Journal of clinical endocrinology and metabolism - 1 May 2012
Abermil Nassera, Guillaud-Bataille Marine, Burnichon Nelly, Venisse Annabelle, Manivet Philippe, Guignat Laurence, Drui Delphine, Chupin Maurice, Josseaume Claire, Affres Hélène, Plouin Pierre-François, Bertherat Jérôme, Jeunemaître Xavier, Gimenez-Roqueplo Anne-Paule
Abstract excerpt
CONTEXT: TMEM127 is a novel pheochromocytoma (PCC) susceptibility gene. OBJECTIVES: Our aim was to clearly determine the indications for TMEM127 genetic testing in patients with PCC and/or paraganglioma (PGL). PATIENTS AND METHODS: Germline DNA from 642 unrelated patients who did not carry mutations in major PCC susceptibility genes was analyzed. Five hundred fifty-nine patients were affected by PCC, 72 by PGL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
